No abstract available
Keywords:
NSCLC; PD-1; PDL-1; TKIs; immunotherapy; oncogene addiction.
MeSH terms
-
Antineoplastic Agents, Immunological / administration & dosage
-
Antineoplastic Agents, Immunological / adverse effects
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / etiology
-
Carcinoma, Non-Small-Cell Lung / pathology*
-
Humans
-
Immunomodulation / drug effects*
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / etiology
-
Lung Neoplasms / pathology*
-
Neoplasm Metastasis
-
Neoplasm Staging
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Immunological